Ultra-Wide-Field OCT Measurements in Patients with Age-Related Macular Degeneration in Relation to Their Visual Function
2024

Ultra-Wide-Field OCT Measurements in Age-Related Macular Degeneration

Sample size: 343 publication 10 minutes Evidence: moderate

Author Information

Author(s): Gawęcki Maciej, Kiciński Krzysztof, Kucharczuk Jan, Teper Sławomir, Hubert Magdalena, Kuc Tomasz

Primary Institution: Department of Ophthalmology, Pomeranian Hospitals, Wejherowo, Poland

Hypothesis

The study aims to compare choroidal and retinal thickness in age-related macular degeneration with a healthy control group using ultra-wide-field optical coherence tomography.

Conclusion

The study found that choroidal thickness is significantly lower in patients with age-related macular degeneration compared to healthy controls, while retinal thickness remains similar across groups.

Supporting Evidence

  • Choroidal thickness was significantly lower in both dry and wet AMD cohorts compared to controls.
  • Retinal thickness showed no significant variation between the three study groups.
  • Visual impairment correlated with older age and smaller retinal thickness in the dry AMD subgroup.
  • Anti-VEGF treatment was associated with lower choroidal thickness in wet AMD patients.
  • Patients with treatment-naïve wet AMD did not show significant choroidal thickness loss.

Takeaway

Doctors used a special camera to look at the eyes of people with a common eye disease and found that the part of the eye that helps with vision is thinner in those with the disease compared to healthy people.

Methodology

The study included measurements from patients with dry AMD, wet AMD, and healthy controls using ultra-wide-field optical coherence tomography.

Potential Biases

Potential bias may arise from the selection of participants from a specific treatment program.

Limitations

The study excluded patients with significant opacity of ophthalmic media and those with poor-quality scans, which may limit the generalizability of the findings.

Participant Demographics

Participants included 74 with dry AMD, 86 with wet AMD, and 53 healthy controls, with a mean age of 68.13 years for controls and 74.46 years for AMD patients.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/diagnostics14242868

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication